BOD Motive?, page-78

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 78 Last

Share
Profile

Follow
ravanelli77

2,889 Posts.

285

17/04/22

16:55

Post #: 60888355
Share

Originally posted by Red bar: ↑

Totally agree with this!
I really think this is just a strategic move. The BOD would most likely have to endorse this takeover, shareholders will not accept 11.5. Hence why Pfizer made a separate offer being the partnership agreement. They know the vast majority of us are very smart investors they cannot treat us like fools and rug pull us from what could be an investment of lifetime paying a handsome dividend in the future!! They can try at a measly 11.5 cents but they will not succeed, especially when so many investors purchased way above this parcel price!! I mean seriously! The company only had three capital raises since it's existence and two of those raises were at or slightly above $0.20 to sophisticated investors!! The more recent raise at 5.7 cents was several months ago but there is still way more upside than just a 2 x Also we need to consider that FIL purchased millions of stock in the 30s and 40 cent region too. The BOD would know that it's up to us to make a decision at the end of the day IMO they've taken a gamble IMO ( hopefully one that will pay off handsomely) and they know that we are not mugs!

On a separate note look at all the extra interest this morning... I think Pfizer is going to have a hard time capping the price at 11.5 cents!! Let's chip away at this wall troops and off to the races we go... a revised bid ( which I still will highly say no to) would have to be on the cards for sure then!

Quarterly coming should show decent growth compared to last quarter), potentially counter bidders (hopefully from a tech giant) and leftfield announcements most likely as well...

Bring it on!! how exciting this is to watch now, before it was like trying to watch grass grow but now it's like I'm on a jet plane!!

Cheers

Red bar

Expand

Quarterly will disappoint, to undermine the mgt's TO excitement at 11.5c ;-)

dont know if mgt is really able to play this strategic game with/against a billion dollar company like pfizer. Think back at the first US Trial how they handled it. ;-)

market is pricing in the TO as a done deal. The more turnover the more shares will shift into the "yes" camp.

like usual in such situation the days before such an importent event the HC excitement is stellar and wishful thinking and finally proven wrong.

IMO & perception

Last edited by ravanelli77: 17/04/22

RAP Price at posting: 11.5¢ Sentiment: Sell Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

JDO

Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

RBA holds rates as ALP election campaigning kicks off – expect more political focus

HVN

Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate

There are more pages in this discussion • 20 more messages in this thread...

First 78 Last

Add RAP (ASX) to my watchlist

BOD Motive?, page-78

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

RBA holds rates as ALP election campaigning kicks off – expect more political focus

Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate

Featured News